Back to Search Start Over

Impact of cystinosin glycosylation on protein stability by differential dynamic SILAC

Authors :
Nevo, Nathalie
Thomas, Lucie
Chhuon, Cerina
Andrzejewska, Zuzanna
Lipecka, Joanna
Guillonneau, François
Bailleux, Anne
Edelman, Aleksander
Antignac, Corinne
Guerrera, Ida Chiara
Laboratoire des Maladies Rénales Héréditaires
Imagine - Institut des maladies génétiques (IMAGINE - U1163)
Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Université Sorbonne Paris Cité (USPC)
Structure Fédérative de Recherche Necker (SFR Necker - UMS 3633 / US24)
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Descartes - Paris 5 (UPD5)-Centre National de la Recherche Scientifique (CNRS)
Institut de psychiatrie et neurosciences (U894 / UMS 1266)
Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Plateforme protéomique 3P5 [Institut Cochin] (3P5)
Institut Cochin (IC UM3 (UMR 8104 / U1016))
Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)
Institut Necker Enfants-Malades (INEM - UM 111 (UMR 8253 / U1151))
Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)
Service de Génétique Médicale [CHU Necker]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Necker - Enfants Malades [AP-HP]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
ANR-10-IAHU-0001,Imagine,Institut Hospitalo-Universitaire Imagine(2010)
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)
Guerrera, Ida Chiara
Instituts Hospitalo-Universitaires - Institut Hospitalo-Universitaire Imagine - - Imagine2010 - ANR-10-IAHU-0001 - IAHU - VALID
Imagine - Institut des maladies génétiques ( IMAGINE - U1163 )
Centre National de la Recherche Scientifique ( CNRS ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Université Paris Descartes - Paris 5 ( UPD5 ) -Centre National de la Recherche Scientifique ( CNRS ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Université Paris Descartes - Paris 5 ( UPD5 )
Université Sorbonne Paris Cité ( USPC )
Structure Fédérative de Recherche Necker ( SFR Necker - UMS 3633 / US24 )
Assistance publique - Hôpitaux de Paris (AP-HP)-Université Paris Descartes - Paris 5 ( UPD5 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS )
Centre de Psychiatrie et Neurosciences ( CPN - U894 )
Université Paris Descartes - Paris 5 ( UPD5 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM )
Plateforme protéomique 3P5 [Institut Cochin] ( 3P5 )
Institut Cochin ( UM3 (UMR 8104 / U1016) )
Université Paris Descartes - Paris 5 ( UPD5 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ) -Université Paris Descartes - Paris 5 ( UPD5 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS )
Institut Necker Enfants-Malades (INEM) ( INEM - UM 111 (UMR 8253 / U1151) )
Université Paris Descartes - Paris 5 ( UPD5 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS )
Assistance publique - Hôpitaux de Paris (AP-HP)-CHU Necker - Enfants Malades [AP-HP]
ANR-10-IAHU-0001/10-IAHU-0001,Imagine,Imagine ( 2010 )
Source :
Molecular and Cellular Proteomics, Molecular and Cellular Proteomics, American Society for Biochemistry and Molecular Biology, 2017, [Epub ahead of print]. ⟨10.1074/mcp.M116.063867⟩, Molecular and Cellular Proteomics, 2017, [Epub ahead of print]. ⟨10.1074/mcp.M116.063867⟩, Molecular and Cellular Proteomics, American Society for Biochemistry and Molecular Biology, 2017, [Epub ahead of print]. 〈10.1074/mcp.M116.063867〉
Publication Year :
2017
Publisher :
HAL CCSD, 2017.

Abstract

International audience; Cystinosis is a rare autosomal recessive lysosomal storage disorder characterized by intralysosomal accumulation of cystine. The causative gene for cystinosis is CTNS, which encodes the protein cystinosin, a lysosomal proton-driven cystine transporter. Over 100 mutations have been reported, leading to varying disease severity, often in correlation with residual cystinosin activity as a transporter and with maintenance of its protein-protein interactions. In this study, we focus on the ΔITILELP mutation, the only mutation reported that sometimes leads to severe forms, inconsistent with its residual transported activity. ΔITILELP is a deletion that eliminates a consensus site on N66, one of the protein seven glycosylation sites. Our hypothesis was that the ΔITILELP mutant is less stable and undergoes faster degradation. Our dynamic SILAC study clearly showed that wild-type cystinosin is very stable, while ΔITILELP is degraded three times more rapidly. Additional lysosome inhibition experiments confirmed ΔITILELP instability and showed that the degradation was mainly lysosomal. We observed that in the lysosome, ΔITILELP is still capable of interacting with the V-ATPase complex and some members of the mTOR pathway, similar to the wild-type protein. Intriguingly, our interactomic and immunofluorescence studies showed that ΔITILELP is partially retained at the endoplasmic reticulum (ER). We proposed that the ΔITILELP mutation causes protein misfolding, ER retention and inability to be processed in the Golgi apparatus, and we demonstrated that ΔITILELP carries high-mannose glycans on all six of its remaining glycosylation sites. We found that the high turnover of ΔITILELP, due to its immature glycosylation state in combination with low transport activity, might be responsible for the phenotype observed in some patients. Data are available via ProteomeXchange with identifier PXD004948, PXD005357 and on Panorama Public at https://panoramaweb.org/labkey/Guerrera.url.

Details

Language :
English
ISSN :
15359476 and 15359484
Database :
OpenAIRE
Journal :
Molecular and Cellular Proteomics, Molecular and Cellular Proteomics, American Society for Biochemistry and Molecular Biology, 2017, [Epub ahead of print]. ⟨10.1074/mcp.M116.063867⟩, Molecular and Cellular Proteomics, 2017, [Epub ahead of print]. ⟨10.1074/mcp.M116.063867⟩, Molecular and Cellular Proteomics, American Society for Biochemistry and Molecular Biology, 2017, [Epub ahead of print]. 〈10.1074/mcp.M116.063867〉
Accession number :
edsair.dedup.wf.001..f88981076c621fcee2a7978e134c54b2
Full Text :
https://doi.org/10.1074/mcp.M116.063867⟩